Neuphoria Therapeutics Inc.
NEUPNasdaqCIK 1191070HealthcareFiscal year ends Jun 30
Income statement
| Line item | Unit | period not labelled2023-09-30 | period not labelled2023-12-31 | period not labelled2024-03-31 | Q4 FY20242024-06-30 | Q1 FY20252024-09-30 | Q2 FY20252024-12-31 | Q3 FY20252025-03-31 | Q4 FY20252025-06-30 | Q1 FY20262025-09-30 | Q2 FY20262025-12-31 | Q3 FY20262026-03-31 | Q4 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | 0.7Revenue, Q2 FY2025, three months to 2024-12-31$662.7k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 15.0Revenue, Q3 FY2025, three months to 2025-03-31$15.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (0.0)Revenue, Q4 FY2025, three months to 2025-06-30−$13.3k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-09-29, accession 0001193125-25-223338. Derived: 12-month figure less the 9-month figure.Report this figure | not reported | not reported | not reported | not reported |
| Research and development | $m | 3.1Research and development, period not labelled, three months to 2023-09-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | 2.0Research and development, period not labelled, three months to 2023-12-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | 1.2Research and development, period not labelled, three months to 2024-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 3.1Research and development, Q4 FY2024, three months to 2024-06-30$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-09-29, accession 0001193125-25-223338. Derived: 12-month figure less the 9-month figure.Report this figure | 1.9Research and development, Q1 FY2025, three months to 2024-09-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 1.7Research and development, Q2 FY2025, three months to 2024-12-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 1.6Research and development, Q3 FY2025, three months to 2025-03-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 3.8Research and development, Q4 FY2025, three months to 2025-06-30$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-09-29, accession 0001193125-25-223338. Derived: 12-month figure less the 9-month figure.Report this figure | 3.8Research and development, Q1 FY2026, three months to 2025-09-30$3.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 0.7Research and development, Q2 FY2026, three months to 2025-12-31$697.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | not reported | not reported |
| Operating income | $m | (5.5)Operating income, period not labelled, three months to 2023-09-30−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | (4.6)Operating income, period not labelled, three months to 2023-12-31−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | (2.4)Operating income, period not labelled, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | (5.5)Operating income, Q4 FY2024, three months to 2024-06-30−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-09-29, accession 0001193125-25-223338. Derived: 12-month figure less the 9-month figure.Report this figure | (3.6)Operating income, Q1 FY2025, three months to 2024-09-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (3.7)Operating income, Q2 FY2025, three months to 2024-12-31−$3.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 12.0Operating income, Q3 FY2025, three months to 2025-03-31$12.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (5.8)Operating income, Q4 FY2025, three months to 2025-06-30−$5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure | (5.7)Operating income, Q1 FY2026, three months to 2025-09-30−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (4.1)Operating income, Q2 FY2026, three months to 2025-12-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | (1.2)Operating income, Q3 FY2026, three months to 2026-03-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (5.5)Operating income, Q4 FY2026, three months to 2026-06-30−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure |
| Income tax | $m | (0.0)Income tax, period not labelled, three months to 2023-09-30−$34.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | (0.0)Income tax, period not labelled, three months to 2023-12-31−$34.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | 0.0Income tax, period not labelled, three months to 2024-03-31$16.4k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | (0.0)Income tax, Q4 FY2024, three months to 2024-06-30−$34.1k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-09-29, accession 0001193125-25-223338. Derived: 12-month figure less the 9-month figure.Report this figure | (0.1)Income tax, Q1 FY2025, three months to 2024-09-30−$132.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 0.0Income tax, Q2 FY2025, three months to 2024-12-31$11.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | (0.1)Income tax, Q3 FY2025, three months to 2025-03-31−$81.2k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (0.3)Income tax, Q4 FY2025, three months to 2025-06-30−$266.6k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure | (0.0)Income tax, Q1 FY2026, three months to 2025-09-30−$34.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (0.0)Income tax, Q2 FY2026, three months to 2025-12-31−$34.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | (0.0)Income tax, Q3 FY2026, three months to 2026-03-31−$34.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (0.0)Income tax, Q4 FY2026, three months to 2026-06-30−$34.8k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure |
| Net income | $m | (5.5)Net income, period not labelled, three months to 2023-09-30−$5.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | (4.6)Net income, period not labelled, three months to 2023-12-31−$4.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | (2.8)Net income, period not labelled, three months to 2024-03-31−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | (2.7)Net income, Q4 FY2024, three months to 2024-06-30−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-09-29, accession 0001193125-25-223338. Derived: 12-month figure less the 9-month figure.Report this figure | (0.8)Net income, Q1 FY2025, three months to 2024-09-30−$804.8k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (1.9)Net income, Q2 FY2025, three months to 2024-12-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 11.3Net income, Q3 FY2025, three months to 2025-03-31$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (8.9)Net income, Q4 FY2025, three months to 2025-06-30−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure | (9.9)Net income, Q1 FY2026, three months to 2025-09-30−$9.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 1.9Net income, Q2 FY2026, three months to 2025-12-31$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (0.5)Net income, Q3 FY2026, three months to 2026-03-31−$505.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | (4.9)Net income, Q4 FY2026, three months to 2026-06-30−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure |
| Diluted EPS | $ per share | 0.00Diluted EPS, period not labelled, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | (5.31)Diluted EPS, period not labelled, three months to 2023-12-31−$5.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | (2.83)Diluted EPS, period not labelled, three months to 2024-03-31−$2.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | not reported | (0.62)Diluted EPS, Q1 FY2025, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (1.79)Diluted EPS, Q2 FY2025, three months to 2024-12-31−$1.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 6.55Diluted EPS, Q3 FY2025, three months to 2025-03-31$6.55 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | not reported | (4.41)Diluted EPS, Q1 FY2026, three months to 2025-09-30−$4.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (0.77)Diluted EPS, Q2 FY2026, three months to 2025-12-31−$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | (0.09)Diluted EPS, Q3 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | not reported |
| Basic EPS | $ per share | 0.00Basic EPS, period not labelled, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | (5.31)Basic EPS, period not labelled, three months to 2023-12-31−$5.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | (2.83)Basic EPS, period not labelled, three months to 2024-03-31−$2.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | not reported | (0.62)Basic EPS, Q1 FY2025, three months to 2024-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (1.23)Basic EPS, Q2 FY2025, three months to 2024-12-31−$1.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 6.55Basic EPS, Q3 FY2025, three months to 2025-03-31$6.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | not reported | (4.41)Basic EPS, Q1 FY2026, three months to 2025-09-30−$4.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 0.41Basic EPS, Q2 FY2026, three months to 2025-12-31$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | (0.09)Basic EPS, Q3 FY2026, three months to 2026-03-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | not reported |
Balance sheet
| Line item | Unit | period not labelled2023-09-30 | period not labelled2023-12-31 | period not labelled2024-03-31 | FY20242024-06-30 | Q1 FY20252024-09-30 | Q2 FY20252024-12-31 | Q3 FY20252025-03-31 | FY20252025-06-30 | Q1 FY20262025-09-30 | Q2 FY20262025-12-31 | Q3 FY20262026-03-31 | FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 8.1Cash and equivalents, period not labelled, at 2023-09-30$8.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | 10.2Cash and equivalents, period not labelled, at 2023-12-31$10.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | 8.4Cash and equivalents, period not labelled, at 2024-03-31$8.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 12.6Cash and equivalents, FY2024, at 2024-06-30$12.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-09-29, accession 0001193125-25-223338.Report this figure | 8.1Cash and equivalents, Q1 FY2025, at 2024-09-30$8.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 4.3Cash and equivalents, Q2 FY2025, at 2024-12-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 17.0Cash and equivalents, Q3 FY2025, at 2025-03-31$17.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 14.2Cash and equivalents, FY2025, at 2025-06-30$14.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure | 13.6Cash and equivalents, Q1 FY2026, at 2025-09-30$13.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 22.2Cash and equivalents, Q2 FY2026, at 2025-12-31$22.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 19.4Cash and equivalents, Q3 FY2026, at 2026-03-31$19.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 19.9Cash and equivalents, FY2026, at 2026-06-30$19.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure |
| Current assets | $m | not reported | not reported | not reported | 13.2Current assets, FY2024, at 2024-06-30$13.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-09-29, accession 0001193125-25-223338.Report this figure | 8.4Current assets, Q1 FY2025, at 2024-09-30$8.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | 4.4Current assets, Q2 FY2025, at 2024-12-31$4.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | 17.1Current assets, Q3 FY2025, at 2025-03-31$17.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 15.0Current assets, FY2025, at 2025-06-30$15.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure | 14.0Current assets, Q1 FY2026, at 2025-09-30$14.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 23.4Current assets, Q2 FY2026, at 2025-12-31$23.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 21.7Current assets, Q3 FY2026, at 2026-03-31$21.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 21.1Current assets, FY2026, at 2026-06-30$21.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure |
| Total assets | $m | not reported | not reported | not reported | 27.6Total assets, FY2024, at 2024-06-30$27.6m. XBRL concept us-gaap:Assets. 10-K filed 2025-09-29, accession 0001193125-25-223338.Report this figure | 22.9Total assets, Q1 FY2025, at 2024-09-30$22.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | 18.2Total assets, Q2 FY2025, at 2024-12-31$18.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | 30.7Total assets, Q3 FY2025, at 2025-03-31$30.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 28.6Total assets, FY2025, at 2025-06-30$28.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure | 27.3Total assets, Q1 FY2026, at 2025-09-30$27.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 36.6Total assets, Q2 FY2026, at 2025-12-31$36.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 34.8Total assets, Q3 FY2026, at 2026-03-31$34.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 28.7Total assets, FY2026, at 2026-06-30$28.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure |
| Current liabilities | $m | not reported | not reported | not reported | 3.8Current liabilities, FY2024, at 2024-06-30$3.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-09-29, accession 0001193125-25-223338.Report this figure | 2.6Current liabilities, Q1 FY2025, at 2024-09-30$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | 2.1Current liabilities, Q2 FY2025, at 2024-12-31$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | 1.6Current liabilities, Q3 FY2025, at 2025-03-31$1.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 4.2Current liabilities, FY2025, at 2025-06-30$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure | 5.1Current liabilities, Q1 FY2026, at 2025-09-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 2.6Current liabilities, Q2 FY2026, at 2025-12-31$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 1.5Current liabilities, Q3 FY2026, at 2026-03-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 0.8Current liabilities, FY2026, at 2026-06-30$756.6k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure |
| Total liabilities | $m | not reported | not reported | not reported | 10.2Total liabilities, FY2024, at 2024-06-30$10.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-09-29, accession 0001193125-25-223338.Report this figure | 5.8Total liabilities, Q1 FY2025, at 2024-09-30$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | 4.4Total liabilities, Q2 FY2025, at 2024-12-31$4.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-02-14, accession 0000950170-25-020473.Report this figure | 4.7Total liabilities, Q3 FY2025, at 2025-03-31$4.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 9.6Total liabilities, FY2025, at 2025-06-30$9.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure | 14.8Total liabilities, Q1 FY2026, at 2025-09-30$14.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | 6.9Total liabilities, Q2 FY2026, at 2025-12-31$6.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-02-17, accession 0001193125-26-054509.Report this figure | 5.4Total liabilities, Q3 FY2026, at 2026-03-31$5.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 4.1Total liabilities, FY2026, at 2026-06-30$4.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure |
| Shareholders' equity | $m | 17.2Shareholders' equity, period not labelled, at 2023-09-30$17.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 19.5Shareholders' equity, period not labelled, at 2023-12-31$19.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 17.9Shareholders' equity, period not labelled, at 2024-03-31$17.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-20, accession 0000950170-25-075175.Report this figure | 17.5Shareholders' equity, FY2024, at 2024-06-30$17.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure | 17.1Shareholders' equity, Q1 FY2025, at 2024-09-30$17.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 13.7Shareholders' equity, Q2 FY2025, at 2024-12-31$13.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 26.0Shareholders' equity, Q3 FY2025, at 2025-03-31$26.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 19.0Shareholders' equity, FY2025, at 2025-06-30$19.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure | 12.5Shareholders' equity, Q1 FY2026, at 2025-09-30$12.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 29.7Shareholders' equity, Q2 FY2026, at 2025-12-31$29.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 29.4Shareholders' equity, Q3 FY2026, at 2026-03-31$29.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-15, accession 0001193125-26-225442.Report this figure | 24.6Shareholders' equity, FY2026, at 2026-06-30$24.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-09-18, accession 0001193125-26-395536.Report this figure |
Cash flow
| Line item | Unit | period not labelled2023-09-30 | period not labelled2023-12-31 | period not labelled2024-03-31 | Q4 FY20242024-06-30 | Q1 FY20252024-09-30 | Q2 FY20252024-12-31 | Q3 FY20252025-03-31 | Q4 FY20252025-06-30 | Q1 FY20262025-09-30 | Q2 FY20262025-12-31 | Q3 FY20262026-03-31 | Q4 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (4.4)Operating cash flow, period not labelled, three months to 2023-09-30−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0000950170-24-127032.Report this figure | (3.9)Operating cash flow, period not labelled, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-02-14, accession 0000950170-25-020473. Derived: 6-month figure less the 3-month figure.Report this figure | (3.3)Operating cash flow, period not labelled, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-20, accession 0000950170-25-075175. Derived: 9-month figure less the 6-month figure.Report this figure | (3.0)Operating cash flow, Q4 FY2024, three months to 2024-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-09-29, accession 0001193125-25-223338. Derived: 12-month figure less the 9-month figure.Report this figure | (4.4)Operating cash flow, Q1 FY2025, three months to 2024-09-30−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (3.4)Operating cash flow, Q2 FY2025, three months to 2024-12-31−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001193125-26-054509. Derived: 6-month figure less the 3-month figure.Report this figure | 11.5Operating cash flow, Q3 FY2025, three months to 2025-03-31$11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-225442. Derived: 9-month figure less the 6-month figure.Report this figure | (3.6)Operating cash flow, Q4 FY2025, three months to 2025-06-30−$3.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure | (3.8)Operating cash flow, Q1 FY2026, three months to 2025-09-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001193125-25-281579.Report this figure | (6.4)Operating cash flow, Q2 FY2026, three months to 2025-12-31−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-17, accession 0001193125-26-054509. Derived: 6-month figure less the 3-month figure.Report this figure | (3.3)Operating cash flow, Q3 FY2026, three months to 2026-03-31−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001193125-26-225442. Derived: 9-month figure less the 6-month figure.Report this figure | 1.2Operating cash flow, Q4 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-09-18, accession 0001193125-26-395536. Derived: 12-month figure less the 9-month figure.Report this figure |
Shares
| Line item | Unit | period not labelled2023-09-30 | period not labelled2023-12-31 | period not labelled2024-03-31 | Q1 FY20252024-09-30 | Q2 FY20252024-12-31 | Q3 FY20252025-03-31 | Q1 FY20262025-09-30 | Q2 FY20262025-12-31 | Q3 FY20262026-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 1,496 | 0.9 | 1.0 | 1.3 | 1.6 | 1.7 | 2.2 | 4.5 | 5.4 |
Shares outstanding: 5.41m at Sep 17, 2026, from the cover of the 10-K filed Sep 18, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. Listed shows no prices and gives no investment advice.